Clinical Trial Update: Active Comparator Study of Generex Oral-lyn™ Spray and Injected Human Insulin [Phase 3]

View source ↗

Summary

Phase 3 active-comparator trial comparing Generex Oral-lyn spray with injected human insulin in diabetes mellitus patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Injected Human Insulin (insulin)
• Oral-lyn Spray (insulin)

Snippet

Sponsor: Generex Biotechnology Corp. | Conditions: Diabetes Mellitus | Phase 3 | Status: UNKNOWN